| Annual · values | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | -447746 USD | -2.93 M USD | -2.76 M USD | -2.24 M USD |
| Depreciation & Amortization | 20468 USD | 62738 USD | 48771 USD | 14849 USD |
| Stock-Based Compensation | 98554 USD | 59803 USD | 32831 USD | 2910 USD |
| Capital Expenditures | 107 USD | 11111 USD | 15251 USD | 121260 USD |
| Cash Flow from Investing | -107 USD | -11111 USD | -15251 USD | -121260 USD |
| Cash Flow from Financing | -332819 USD | 2.06 M USD | 6.05 M USD | 2.27 M USD |
| Dividends Paid | — | — | — | — |
| Stock Buybacks | — | — | — | — |
| Free Cash Flow | -447853 USD | -2.94 M USD | -2.77 M USD | -2.37 M USD |
Syra Health Corp. is a specialized company operating in the healthcare services sector. It primarily focuses on providing comprehensive solutions that aim to enhance healthcare delivery and patient outcomes. The company offers a diverse range of services, including health literacy programs, telemedicine solutions, and healthcare staffing services, catering to the evolving needs of the healthcare industry. Additionally, Syra Health Corp. places a strong emphasis on leveraging technology to improve efficiency and accessibility in healthcare settings, impacting both urban and remote areas. By addressing crucial health education and service delivery challenges, the company plays a significant role in shaping the future of healthcare services. As healthcare continues to be a pivotal industry globally, Syra Health Corp.'s contributions assist in bridging gaps within the system, ultimately supporting the industry’s shift towards more patient-centered and efficient care models.